Flexion Therapeutics, Inc. EBITDA Margin 2014-2021 | FLXN
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Flexion Therapeutics, Inc. (FLXN) over the last 10 years. The current EBITDA margin for Flexion Therapeutics, Inc. as of September 30, 2021 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2021-09-30 | $0.10B | $-0.06B | -63.00% |
| 2021-06-30 | $0.10B | $-0.06B | -57.28% |
| 2021-03-31 | $0.09B | $-0.07B | -77.78% |
| 2020-12-31 | $0.09B | $-0.08B | -95.29% |
| 2020-09-30 | $0.08B | $-0.10B | -116.87% |
| 2020-06-30 | $0.08B | $-0.11B | -138.27% |
| 2020-03-31 | $0.08B | $-0.12B | -143.37% |
| 2019-12-31 | $0.07B | $-0.13B | -170.27% |
| 2019-09-30 | $0.06B | $-0.14B | -225.00% |
| 2019-06-30 | $0.05B | $-0.14B | -317.78% |
| 2019-03-31 | $0.03B | $-0.15B | -471.88% |
| 2018-12-31 | $0.02B | $-0.15B | -656.52% |
